User
Favorite list
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
The biannual DCID (Dendritic Cells Immunotherapy Days) return as a unique networking event this fall. Bringing experts together within the immunotherapy community, we provide a platform to shape the future of DC-based therapies. This year, we will also extend further into next generation vaccines. Focusing on nanomaterial, nanoparticle, and next generation vaccine approaches. Do not miss the chance to be a part of this great community of experts.
Save the date in your calendar and check out the final program below.
Simply fill in the form below to participate.
Scientific committee members:
Li Tang, Evelien Smits, Jolanda DeVries, Nina Bhardwaj
Session topics:
Regulation and manufacturing of cancer vaccines
John Campbell, Koen Bezemer, Thomas Hinz
Advanced biomaterials for vaccine design
Li Tang, Joseph Barchi, Renata Stripecke, Matthias Bros, Helena Florindo, Bruno de Geest
Cancer vaccines and combination therapy
Eva Lion, Bart Neyns, Marta Santisteban Eslava, Harm Westdorp, Andrew Jackson, Stuart Curbishley
Miltenyi Biotec B.V. & Co. KG
Friedrich-Ebert-Straße 68,
51429 Bergisch Gladbach, Germany
Disclaimer:
Miltenyi Biotec is the organizer of this symposium as a platform for scientific exchange.
The statements and other contributions presented at the meeting and the views expressed therein are those of the attending experts and do not necessarily represent the policy or opinion of Miltenyi Biotec or any institution the respective expert may be associated with. Neither Miltenyi Biotec nor any of its directors or employees give any representation or warranty as to the reliability, accuracy, or completeness of the content thereof. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. This notice must accompany any further distribution of this document.
Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. CliniMACS Prodigy, MACS, and the MACS logo are registered trademarks or trademarks of Miltenyi Biotec B.V. & Co. KG and/or its affiliates in various countries worldwide. Copyright © 2019 Miltenyi Biotec B.V. & Co. KG and/or its affiliates. All rights reserved.
Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.
Download PDF
